WUXI BIOLOGICS-0,0000083WUXI BIOLOGICS-0,0000083WUXI BIOLOGICS-0,0000083

WUXI BIOLOGICS-0,0000083

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
0.06EUR
Revenue estimate
‪1.03 B‬EUR
Market capitalization
‪6.46 B‬EUR
‪435.76 M‬EUR
‪2.18 B‬EUR
‪3.07 B‬
Beta (1Y)
1.39

About WUXI BIOLOGICS (CAYMAN) INC

CEO
Zhi Sheng Chen
Headquarters
Wuxi
Employees (FY)
‪12.74 K‬
Founded
2014
ISIN
KYG970081173
FIGI
BBG00L2RGBR0
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. Its products include antibody drugs, biological medicines, and other tablets, as well as provides research material generation, sterility assurance programs, clinical trials, and translational oncology research services. The company was founded on February 27, 2014 and is headquartered in Wuxi, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange WUXI BIOLOGICS-0,0000083 stocks are traded under the ticker 1FW2.
WUXI BIOLOGICS-0,0000083 is going to release the next earnings report on Aug 19, 2024. Keep track of upcoming events with our Earnings Calendar.
1FW2 earnings for the last quarter are 0.08 EUR per share, whereas the estimation was 0.07 EUR resulting in a 18.18% surprise. The estimated earnings for the next quarter are 0.03 EUR per share. See more details about WUXI BIOLOGICS-0,0000083 earnings.
WUXI BIOLOGICS-0,0000083 revenue for the last quarter amounts to ‪1.07 B‬ EUR despite the estimated figure of ‪1.03 B‬ EUR. In the next quarter revenue is expected to reach ‪1.07 B‬ EUR.
Yes, you can track WUXI BIOLOGICS-0,0000083 financials in yearly and quarterly reports right on TradingView.
1FW2 net income for the last quarter is ‪141.99 M‬ EUR, while the quarter before that showed ‪299.82 M‬ EUR of net income which accounts for −52.64% change. Track more WUXI BIOLOGICS-0,0000083 financial stats to get the full picture.
No, 1FW2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1FW2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WUXI BIOLOGICS-0,0000083 stock right from TradingView charts — choose your broker and connect to your account.
1FW2 reached its all-time high on Oct 25, 2007 with the price of 79.2900 EUR, and its all-time low was 1.5030 EUR and was reached on Apr 19, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has ‪12.74 K‬ employees. See our rating of the largest employees — is WUXI BIOLOGICS-0,0000083 on this list?
We've gathered analysts' opinions on WUXI BIOLOGICS-0,0000083 future price: according to them, 1FW2 price has a max estimate of 6.36 EUR and a min estimate of 1.43 EUR. Read a more detailed WUXI BIOLOGICS-0,0000083 forecast: see what analysts think of WUXI BIOLOGICS-0,0000083 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WUXI BIOLOGICS-0,0000083 EBITDA is ‪683.92 M‬ EUR, and current EBITDA margin is 31.22%. See more stats in WUXI BIOLOGICS-0,0000083 financial statements.